The burden of parvovirus B19 infection in women of childbearing age in England and Wales
about
Parvovirus B19 infection in human pregnancyInferring influenza infection attack rate from seroprevalence dataParenteral transmission of the novel human parvovirus PARV4.High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan.Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infectionsSeroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.Seroprevalence of parvovirus B19 in the German population.Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.Infection and immunity for human parvovirus B19 in patients with febrile exanthema.The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.Parvovirus B19 in pregnancy: possible consequences of vertical transmission.Symptomatic parvovirus B19 infection caused by blood component transfusion.The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy?Parvovirus B19 Achievements and Challenges
P2860
Q24594590-9B3902FF-51CF-4F3E-AFED-CCDF873E0C50Q30361006-F07B41C0-D027-49DB-B74A-FFD2E675AECBQ33800906-0D9023F9-35D6-4C19-BDBA-51B3EE45D9D5Q34039466-5696E4C8-B451-436C-B191-DE438C19E8F6Q34120900-E9BF6764-5172-4E41-847B-CF063ED766ADQ34706552-F683BA30-9B58-400D-8D49-2C6E5E3AC74EQ35128072-3D236E04-983A-40D0-A98E-A0A8AC4C4878Q36747943-4FA9FE12-7C59-4758-9A3F-141110D8A075Q36974336-882B9F90-8A14-4548-8291-F263E8F002E6Q39829152-F3FA391F-A3B7-45C4-BF22-ED935191A7D7Q40132449-FA1EDFE6-4562-4B31-ABD8-BEEE0B64D79DQ40321614-F67805F0-8D20-40BA-BB73-162AD0F36C48Q44238813-01B3218A-F150-4A36-914C-B43C77F3D6E9Q47832474-4846CDA5-8097-411F-ADDB-5F91DA06EADBQ50545205-109F3665-0920-401A-8214-B0BDF79BF404Q51122558-A833BEB9-A862-4DE4-B77F-6AA5351FCFC0Q58666387-23E5FB3D-3720-4A90-9DDF-BA6E929C33E8
P2860
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
description
article
@en
im November 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2007
@uk
name
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
@en
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
@nl
type
label
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
@en
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
@nl
prefLabel
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
@en
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
@nl
P2093
P2860
P1476
The burden of parvovirus B19 infection in women of childbearing age in England and Wales
@en
P2093
L M Hesketh
N J Andrews
P2860
P304
P356
10.1017/S0950268807007856
P407
P577
2007-11-01T00:00:00Z